MCA logo

PUBLIC PORTAL

MEDICALLY REVIEWED

HSA approves the first JAK inhibitor for moderate-to-severe atopic dermatitis: baricitinib (Olumiant)

baricitinib olumiant for atopic dermaitis eczema

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

energy drinks gatorade
How Do Energy Drinks Work?

Energy drinks have become increasingly popular, offering a quick and convenient boost for those in need of a pick-me-up. With bold claims of increased energy, enhanced mental focus, and improved physical performance, it’s no wonder that these beverages have gained a strong following. But do energy drinks truly live up to their promises? In this article, we’ll explore the science behind energy drinks and evaluate their effectiveness in delivering the benefits they claim.

Read More »